1
|
Schepetkin IA, Özek G, Özek T, Kirpotina LN, Khlebnikov AI, Klein RA, Quinn MT. Neutrophil Immunomodulatory Activity of Farnesene, a Component of Artemisia dracunculus Essential Oils. Pharmaceuticals (Basel) 2022; 15:642. [PMID: 35631467 PMCID: PMC9143003 DOI: 10.3390/ph15050642] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 05/18/2022] [Accepted: 05/19/2022] [Indexed: 12/20/2022] Open
Abstract
Despite their reported therapeutic properties, not much is known about the immunomodulatory activity of essential oils present in Artemisia species. We isolated essential oils from the flowers and leaves of five Artemisia species: A. tridentata, A. ludoviciana, A. dracunculus, A. frigida, and A. cana. The chemical composition of the Artemisia essential oil samples had similarities and differences as compared to those previously reported in the literature. The main components of essential oils obtained from A. tridentata, A. ludoviciana, A. frigida, and A. cana were camphor (23.0-51.3%), 1,8-cineole (5.7-30.0%), camphene (1.6-7.7%), borneol (2.3-14.6%), artemisiole (1.2-7.5%), terpinen-4-ol (2.0-6.9%), α-pinene (0.8-3.9%), and santolinatriene (0.7-3.5%). Essential oils from A. dracunculus were enriched in methyl chavicol (38.8-42.9%), methyl eugenol (26.1-26.4%), terpinolene (5.5-8.8%), (E/Z)-β-ocimene (7.3-16.0%), β-phellandrene (1.3-2.2%), p-cymen-8-ol (0.9-2.3%), and xanthoxylin (1.2-2.2%). A comparison across species also demonstrated that some compounds were present in only one Artemisia species. Although Artemisia essential oils were weak activators of human neutrophils, they were relatively more potent in inhibiting subsequent neutrophil Ca2+ mobilization with N-formyl peptide receptor 1 (FPR1) agonist fMLF- and FPR2 agonist WKYMVM, with the most potent being essential oils from A. dracunculus. Further analysis of unique compounds found in A. dracunculus showed that farnesene, a compound with a similar hydrocarbon structure as lipoxin A4, inhibited Ca2+ influx induced in human neutrophils by fMLF (IC50 = 1.2 μM), WKYMVM (IC50 = 1.4 μM), or interleukin 8 (IC50 = 2.6 μM). Pretreatment with A. dracunculus essential oils and farnesene also inhibited human neutrophil chemotaxis induced by fMLF, suggesting these treatments down-regulated human neutrophil responses to inflammatory chemoattractants. Thus, our studies have identified farnesene as a potential anti-inflammatory modulator of human neutrophils.
Collapse
Affiliation(s)
- Igor A. Schepetkin
- Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA; (I.A.S.); (L.N.K.)
| | - Gulmira Özek
- Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey; (G.Ö.); (T.Ö.)
| | - Temel Özek
- Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey; (G.Ö.); (T.Ö.)
| | - Liliya N. Kirpotina
- Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA; (I.A.S.); (L.N.K.)
| | | | - Robyn A. Klein
- Department of Plant Sciences and Plant Pathology, Montana State University, Bozeman, MT 59717, USA;
| | - Mark T. Quinn
- Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA; (I.A.S.); (L.N.K.)
| |
Collapse
|
2
|
Sharifi-Rad J, Herrera-Bravo J, Semwal P, Painuli S, Badoni H, Ezzat SM, Farid MM, Merghany RM, Aborehab NM, Salem MA, Sen S, Acharya K, Lapava N, Martorell M, Tynybekov B, Calina D, Cho WC. Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2022; 2022:5628601. [PMID: 36105486 PMCID: PMC9467740 DOI: 10.1155/2022/5628601] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 08/07/2022] [Accepted: 08/12/2022] [Indexed: 12/11/2022]
Abstract
Artemisia plants are traditional and ethnopharmacologically used to treat several diseases and in addition in food, spices, and beverages. The genus is widely distributed in all continents except the Antarctica, and traditional medicine has been used as antimalarial, antioxidant, anticancer, antinociceptive, anti-inflammatory, and antiviral agents. This review is aimed at systematizing scientific data on the geographical distribution, chemical composition, and pharmacological and toxicological profiles of the Artemisia genus. Data from the literature on Artemisia plants were taken using electronic databases such as PubMed/MEDLINE, Scopus, and Web of Science. Selected papers for this updated study included data about phytochemicals, preclinical pharmacological experimental studies with molecular mechanisms included, clinical studies, and toxicological and safety data. In addition, ancient texts and books were consulted. The essential oils and phytochemicals of the Artemisia genus have reported important biological activities, among them the artemisinin, a sesquiterpene lactone, with antimalarial activity. Artemisia absinthium L. is one of the most famous Artemisia spp. due to its use in the production of the absinthe drink which is restricted in most countries because of neurotoxicity. The analyzed studies confirmed that Artemisia plants have many traditional and pharmacological applications. However, scientific data are limited to clinical and toxicological research. Therefore, further research is needed on these aspects to understand the full therapeutic potential and molecular pharmacological mechanisms of this medicinal species.
Collapse
Affiliation(s)
| | - Jesús Herrera-Bravo
- 2Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Chile
- 3Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco 4811230, Chile
| | - Prabhakar Semwal
- 4Department of Life Sciences, Graphic Era Deemed To Be University, Dehradun, 248002, Uttarakhand, India
| | - Sakshi Painuli
- 5Uttarakhand Council for Biotechnology (UCB), Prem Nagar, Dehradun, 248007 Uttarakhand, India
| | - Himani Badoni
- 6Department of Biotechnology, School of Applied and Life Sciences, Uttaranchal University, Prem Nagar, Dehradun, 248007, Uttarakhand, India
| | - Shahira M. Ezzat
- 7Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
- 8Department of Pharmacognosy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza 12451, Egypt
| | - Mai M. Farid
- 9Department of Phytochemistry and Plant Systematics, National Research Centre, 33 El Bohouth St., Dokki, P. O. 12622, Giza, Egypt
| | - Rana M. Merghany
- 10Pharmacognosy Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Bohouth street, Dokki, Giza, Egypt
| | - Nora M. Aborehab
- 11Department of Biochemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza 12451, Egypt
| | - Mohamed A. Salem
- 12Department of Pharmacognosy, Faculty of Pharmacy, Menoufia University, Gamal Abd El Nasr St., Shibin El Kom, 32511 Menoufia, Egypt
| | - Surjit Sen
- 13Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, Kolkata 700019, India
- 14Department of Botany, Fakir Chand College, Diamond Harbour, West Bengal 743331, India
| | - Krishnendu Acharya
- 13Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, Kolkata 700019, India
| | - Natallia Lapava
- 15Medicine Standardization Department, Vitebsk State Medical University, Belarus
| | - Miquel Martorell
- 16Department of Nutrition and Dietetics, Faculty of Pharmacy, And Centre for Healthy Living, University of Concepción, Concepción, Chile
- 17Universidad de Concepción, Unidad de Desarrollo Tecnológico (UDT), 4070386 Concepción, Chile
| | - Bekzat Tynybekov
- 18Department of Biodiversity of Bioresources, Al-Farabi Kazakh National University, Almaty, Kazakhstan
| | - Daniela Calina
- 19Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
| | - William C. Cho
- 20Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
| |
Collapse
|
3
|
van Baren CM, González SB, Bandoni AL, Di Leo Lira P, Bucio MA, Hernández-Barragán A, Joseph-Nathan P. GC-FID-MS and X-ray Diffraction for the Detailed Evaluation of the Volatiles From Senecio filaginoides. Nat Prod Commun 2020. [DOI: 10.1177/1934578x20968443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The medicinal aromatic plant Senecio filaginoides DC, which is very widespread in the Patagonia region, was harvested at the vegetative, flowering, and fructification stages. The materials were extracted by hydrodistillation, yielding in average 0.34% v/w of essential oils with a pleasant sweet and greenish scent. A total of 56 components were identified by gas chromatography using flame ionization detection and mass spectra measurements, representing 96.1%-97.6% of the total oil. The sesquiterpenoid 10 αH-furanoeremophil-1-one (1) appeared as a major constituent (16.2%-26.9%) of the oil. It could be isolated by cooling the oil at 4°C, thus yielding yellow crystalline solids. Its stereochemistry was assigned by single-crystal X-ray diffraction since previous studies identified the compound with different stereochemistries. The use of classical separation and analytical methodologies remains as a very useful strategy for the correct identification of compounds present in the volatile fraction of a plant and is a route for potential industrial applications.
Collapse
Affiliation(s)
- Catalina M. van Baren
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia-IQUIMEFA (UBA-CONICET), Buenos Aires, Argentina
| | - Silvia B. González
- Universidad Nacional de la Patagonia SJB, Sede Esquel, Facultad de Ciencias Naturales y Ciencias de la Salud, Laboratorio de Investigación de Plantas Aromáticas y Medicinales, Química Orgánica, Esquel, Chubut, Argentina
| | - Arnaldo L. Bandoni
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia-IQUIMEFA (UBA-CONICET), Buenos Aires, Argentina
| | - Paola Di Leo Lira
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia-IQUIMEFA (UBA-CONICET), Buenos Aires, Argentina
- CONICET-Universidad de Buenos Aires. Instituto de la Química y el Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, UBA, Buenos Aires, Argentina
| | - María A. Bucio
- Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico
| | - Angelina Hernández-Barragán
- Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico
| | - Pedro Joseph-Nathan
- Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico
| |
Collapse
|